OBJECTIVES: To review the clinical and laboratory features of 12 cases of nephrogenic
fibrosing dermopathy (NFD) studied at our institution and of 70 previously described cases …

Objective B cells are likely to contribute to the pathogenesis of systemic lupus
erythematosus (SLE), and rituximab induces depletion of B cells. The Exploratory Phase II/III …

Objective To evaluate the efficacy and safety of rituximab in a randomized, double‐blind,
placebo‐controlled phase III trial in patients with lupus nephritis treated concomitantly with …

Objectives This phase III study evaluated the efficacy and safety of rituximab plus
methotrexate (MTX) in patients with active rheumatoid arthritis (RA) who had an inadequate …

Objective To assess the effects of the B lymphocyte stimulator (BLyS)–specific inhibitor
belimumab on immunologic biomarkers, including B cell and T cell populations, and …

Harvesting different species as foods or raw materials calls for differing skills depending on
the species being harvested and the circumstances under which they are being taken. In …

Objective Nephrogenic fibrosing dermopathy (NFD) is a newly recognized cutaneous fibrotic
disorder occurring in individuals with end‐stage renal disease (ESRD). The aim of the …

The EXPLORER study was designed to assess the response to rituximab versus placebo in
patients with moderate to severe extrarenal systemic lupus erythematosus (SLE) receiving …

Natural killer (NK) cells express multiple activating receptors that initiate signaling cascades
through DAP10-or immunoreceptor tyrosine-based activation motif–containing adapters …

T lymphocytes undergo apoptosis in response to cellular stress, including UV exposure and
gamma irradiation. However, the mechanism by which stress stimuli induce apoptosis is not …